Encouraging report for Parkinson’s vaccine

The Michael J. Fox Foundation and Affiris have just reported the first phase I trial data for a novel vaccine targeting alpha synuclein. Click on the link below to read more about this from an article I wrote for the conversation:

https://theconversation.com/first-stage-trial-of-new-vaccine-offers-glimmer-of-hope-to-parkinsons-sufferers-30012

 

Advertisements